Histamine: The quintessential mediator

Journal of Dermatology

Volumn 23, Issue 11, 1996, Pages 735-740

  Greaves, Malcom W ^a   Sabroe, R A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

chronic idiopathic urticaria; high affinity IgE receptors; histamine; histamine receptors; mast cells

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; CELL SURFACE RECEPTOR; CYCLOSPORIN A; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN E RECEPTOR;

AUTOIMMUNITY; BASOPHIL; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONFERENCE PAPER; HISTAMINE RELEASE; INFLAMMATION; MAST CELL; PLASMAPHERESIS; REMISSION; URTICARIA; VASODILATATION;

EID: 0029835872     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02694.x     Document Type: Conference Paper

References (43)

1. Dale HH: On some physiological actions of ergot, J Physiol, 34: 163-206,1906.
2. Dale HH: Progress in autopharmacology. A survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues, Bull Johns Hopkins Hasp, 53: 297-347, 1934.
3. Lewis T: The Blood Vessels of the Human Skin and Their Responses, Shaw and Sons, London, 1927, p 47.
4. Lewis T: The Blood Vessels of the Human Skin and Their Responses, Shaw and Sons, London, 1927, p 288.
5. Simone D A, Alreja M, LaMotte R H: Psychophysical studies of the itch sensation and itchy skin (alloknesis) produced by intracutaneous injection of histamine, Somatosensory Motor Res, 8: 271-279,1991.
6. Greaves MW, Shuster S: Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamineJP/i5w/, 193: 255-267,1967.
7. Cruickshank JG, Williams HR: Scombrotoxic fish poisoning, BrMedJ, il: 739-740, 1978.
8. Gilbert RJ, Hobbs G, Murray CK, Cruickshank JG, Young SEJ: Scombrotoxic fish poisoning: Features of the first 50 incidents to be reported in Britain (19769), ßrAfo//,ii: 71-72,1980.
9. Ferencik M: Formation of histamine during bacterial decarboxylation of histidine in the flesh of some marine fishes.y Hyg Epidemiol Alicrobiol Immunol, 14: 52-60,1970.
10. Marks R, Greaves MW: Vascular reactions to histamine and compound 48/80 in human skin: Suppression by a histamine H2-receptor blocking agent, BrJ Clin Phannacol, 4: 367-369,1977.
11. Robertson I, Greaves MW: Responses of human skin blood vessels to synthetic histamine analogues, BrJ Clin Phannacol, 5: 319-322,1978.
12. Davies MG, Greaves MW: Sensory responses of human skin to synthetic histamine analogues and histamine, BrJ Clin Pharmacol, 9: 461-465,1980.
13. Breathnach SM, Alien R, Milford WA, Greaves MW: Symptomatic dermographism: Natural history, clinical features, laboratory investigations and response to therapy, Clin Exp Dennatol, 8: 463-476,1983.
14. Bleehen SS, Thomas SE, Greaves MW, et al: Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: A multi-centre randomised double-blind study, BrJ Dennatol, 117: 81-88, 1987.
15. ArrangJM, Garbarg M, SchwanzJC: Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor, Nature, 302: 832-837, 1983.
16. ArrangJM, Garbarg M, Lancelot JC, et al: Highly potent and selective ligands for histamine H3-receptors, Nature, 327: 117-123,1987.
17. Ishikawa S, Sperelakis N: A novel class (H,) of histamine receptors of perivascular nerve terminals, Nature, 327: 158-160, 1987.
18. Menkveld GJ, Timmerman H: Inhibition of electrically evoked contractions of guinea-pig ileum preparations mediated by the histamine H, receptor, Eur JPharmacol, 186: 343-347,1990.
19. Brandes LJ, LaBella FS, Glavin GB, et al: Histamine as an imracellular messenger, Biochein Phannacol, 40: 1677-1681,1990.
20. Greaves MW, Sondergaard J: Urticaria pigmentosa and factitious urticaria. Direct evidence for release of histamine and other smooth muscle-contracting agents in dermographic skin, Arch Dennatol 101: 418-425,1970.
21. Kaplan AP, Horâovâ Z, Katz SI: Assessment of tissue fluid histamine levels in patients with urticaria, J Allergy Clin Immunol, 61: 350-354,1978.
22. Okahara K, Murakami T, Yamamoto S, Yata N: Skin microdialysis: Detection of in vivo histamine release in cutaneous allergic reactions, Skin Phannacol, 8: 113-118,1995.
23. Bentley-Phillips CB, Black AK, Greaves MW: Induced tolerance in cold urticaria caused by cold-evoked histamine release, Lancet, ii: 63-66, 1976.
24. Bentley-Phillips CB, Eady RAJ, Greaves MW: Cold urticaria: Inhibition of cold-induced histamine release by Doxantrazole.y Invest Dennatol, 71: 266-268, 1978.
25. 2 and histamine release in cold urticaria, / Allergy Clin Immunol, 78: 458-461,1986.
26. Greaves MW: Mastocytosis, in Champion RH, Burton JL, Edling FJG (eds): Textbook of Dermatology, 5th ed, vol 3, Blackwell Scientific Publications, Oxford, 1992, pp 2065-2072.
27. Lawlor F, Black AK, Murdoch RD, Greaves MW: Symptomatic dermographism: Wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid, BrJ Dermatol, 121: 629-634,1989.
28. Ebertz JM, Hirshman CA, Kettelkamp NS, Uno H, Hanifin JM: Substance P-induced histamine release in human cutaneous mast cells,/ Invest Dermatol, 88: 682-685,1987.
29. Hagermark O: Skin as a response organ for neuropeptides, Clin Exp Dermatol, 12: 136,1987 (abstract).
30. Niimi N, Francis DM, Kennani F, et al: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria, ] Invest Dermatol, 1996. (in press)
31. Kermani F, Niimi N, Francis DM, et'al: Characterization of a noval mast cell-Specific histamine releasing activity in chronic idiopathic urticaria (CIU), J Invest Dermatol, 105: 452, 1995 (abstract).
32. Grattan GEH, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing. autoantibodies with functional properties of anti-IgE in chronic urticaria, Clin Exp Allergy, 21: 695-704, 1991.
33. Hide M, Francis DM, Grattan GEH, Barr RM, Winkelmann RK, Greaves MW: The pathogenesis of chronic idiopathic urticaria: New evidence suggests an auto-immune basis and implications for treatment, Clin Exp Allergy, 24: 624-627,1994.
34. Hide M, Francis DM, Grattan GEH, HakimiJ, Kochan JP, Greaves MW: Autoantibodies ag'ainst the highaffinity IgE receptor as a cause of histamine release in chronic urticaria, N EnglJ Med, 328: 1599-1604, 1993.
35. Fiebiger E, Maurer D, Holub H, et al: Serum IgG autoantibodies directed against the a chain of FcsRI: A selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?, J Clin -Invest, 96: 2606-2612,1995.
36. Witebsky E, Rose NR, Terplan K, PaineJR, Egan RW: Chronic thyroiditis and autoimmunization,/ Am Med Assoc, 164: 1439-1447,1957.
37. Appel SH, Elias SB, Chauvin P: The role of acetylcholine receptor antibodies in myasthenia gravis, Fed Proc, 38: 2381-2385,1979.
38. Grattan GEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW: Plasmapheresis for severe, unremitting, chronic urticaria, Lancet, 339: 1078-1080,1992.
39. Grattan GEH, Walpole DA, Francis DM: Basophil numbers in chronic urticaria, J Eur Acad Dermatol Venereal, 5: S34, 1995.
40. O'Donnell BF, Barlow RJ, Black AK, Greaves MW: Response of severe chronic urticaria to intravenous immunoglobulin (IVIG), Er] Dermatol, 131, (Suppl. 44): 23-24,1994.
41. Casolaro V, Spadaro G, Patella V, Marone G: In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils,/ Immunol, 151: 5563-5573,1993.
42. Stellate C, de Faillis A, Ciccarelli A, et al: Antiinflammatory effect of cyclosporin A on human skin mast cells, J Invest Dermatol, 98: 800-804,1992.
43. Barlow RJ, Black AK, Greaves MW: Treatment of severe, chronic urticaria with cyclosporin A, Eur} Dermatol, 3: 273-275, 1993.